Bausch Sues Sun’s Taro on New Patent for Duobrii Psoriasis Drug – Bloomberg Law
Bausch Sues Sun’s Taro on New Patent for Duobrii Psoriasis Drug Bloomberg Law
In: PATENT NEWS
Bausch Sues Sun’s Taro on New Patent for Duobrii Psoriasis Drug Bloomberg Law
In: PATENT NEWS
Samsung Axes Charger Patents Asserted Against It, Dell, Anker Bloomberg Law
In: PATENT NEWS
Cryptomining Vendor: Competitor Patent Used to Monopolize Texas … Law.com
In: TRADEMARK NEWS
Ryback Puts Vince McMahon on Notice After Getting His Trademark Back Ringside News
In: PATENT NEWS
Regeneron Says Supreme Court Ruling Ends Patent Dispute With Amgen … patents were overly broad and inconsistent with established case law,” said …
In: PATENT NEWS
Sanofi Wins Supreme Court Patent Dispute With Amgen The Wall Street Journal Shaping the Future of Patent Law: The Amgen v. Sanofi Decision and Bite-Sized Monopolies Patently-O Justices Narrow Patent Enablement Scope in Amgen-Sanofi Case (3) Bloomberg Law
In: COPYRIGHT NEWS
Supreme Court rules against Andy Warhol in copyright dispute over Prince portrait CNN
In: PATENT NEWS
… block the PCSK9 receptor involved in LDL cholesterol metabolism—fail to satisfy the Patent Act’s enablement clause, see 35 U. S. C. §112(a).
In: COPYRIGHT NEWS
The next AI battle: Copyright Axios
In: PATENT NEWS
… against Amgen Inc in its bid to revive patents on its cholesterol-lowering drug Repatha over a legal challenge by French rival Sanofi SA.
Designed by Industrial Action
Copyright © 2024 OPUS IP Limited. All Rights Reserved
OPUS IP Limited: COMPANY & OTHER LEGAL INFORMATION